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A BST R AC T  
 
Aim: Hysterectomy is one of the most prevalent surgical intervention in gynecological field. This 
study concerns the requirement and necessity of an endometrial sampling to exclude an unpredictable 
uterine malignancy risk before hysterectomy for benign conditions.   
Methods: This is a retrospective and cross-sectional study involving 307 patients who had 
hysterectomy for benign conditions between years 2014-2018. Prior to hysterectomy, in 162 cases, 
an endometrial sampling was performed ahead (biopsy group) and in 145 cases, hysterectomy was 
performed without obtaining an endometrial sampling earlier on (control group). Pre- and post-
surgical pathological evaluation reports were collected and compared between the groups.  
Results: Features of the patients as mean age, number of previous pregnancies, being at 
postmenopausal status did not vary significantly between two groups. In the biopsy group, 51.2% of 
the patients were in the premenopausal period, 40.7% of the patients had postmenopausal bleeding 
and 52.5% had abnormal uterine bleeding symptoms and these three features were significantly 
higher than in the control group. In the control group, one case (0.7%) had leiomyosarcoma and 
another case (0.7%) had endometrial adenocarcinoma. In the biopsy group, endometrial 
adenocarcinoma was detected in 5 patients (3.1%) as significantly higher than in the control group.  
Conclusion: If there are no symptoms, clinical and radiological findings suggesting an endometrial 
malignancy in patients who planned to undergo a hysterectomy for benign conditions, it is 
unnecessary to perform a routine endometrial biopsy. 
Keywords: Hysterectomy, endometrial biopsy, dilation and curettage, benign uterine conditions, 
endometrial malignancy. 
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Introduction 
Hysterectomy is one of the most frequent 
surgical intervention of our field for the non-
obstetric conditions. Endometriosis, chronic 
pelvic pain, pelvic inflammatory disease and 
uterine prolapses are the main benign 
indications for hysterectomy [1]. Performing 
an endometrial sampling prior to schedule a 
hysterectomy is regarded as a general consent 
in patients with suspicious history and findings 
for pre-malign disease and malignity of the 
endometrium [2-5]. It was reported that 
unexpected   endometrial cancer and any other 
types of malignancies were incidentally found 
0.12-2.7% and 0.19% respectively in 
hysterectomy specimens found in patients with 
benign preoperative indications [6]. For 
determining the type of surgical management 
and deployment, in some patients with uterine 
leiomyoma, endometrial sampling   is applied 
to exclude a risk of underlying 
leiomyosarcoma [7]. 
In patients diagnosed with a pre-malign 
endometrial intraepithelial neoplasia by 
endometrial suction or curettage, endometrial 
carcinoma is found 40% in their hysterectomy 
specimens [8-10]. To reveal the cancer 
diagnosis in patients with abnormal uterine 
bleeding, dilatation and curettage (D&C) is 
reported to be superior to any other 
endometrial sampling methods and for space-
occupying lesions in the uterine cavity, a D&C 
accompanied with hysteroscopy has been 
shown to be more sensitive [11,12]. Also, in 
patients with no lesions in the uterine cavity, 
D&C is the most precious diagnostic method 
to disclose endometrial premalignant lesions 
and any potentially underlying cancers [13]. 
We studied the necessity of endometrial 
sampling before performing hysterectomy for 
benign indications to avoid the risk of 
unpredictable uterine malignancy. 
Methods  
This study is a retrospective and cross-
sectional study which was conducted 
approving by the Clinical Research Ethics 
Committee of Bolu Abant Izzet Baysal 
University (document no: 78/2018). The 
survey consisted of 307 patients who were 
operated a hysterectomy in the Department of 
Gynecology and Obstetrics in Abant Izzet 
Baysal University between January 2014 and 
June 2018. 
 
Study Design  
The data of the patients enrolled in the study 
was collected from the records in the patient 
files and the hospital’s automation software. 
The patients’ main complaints for admitting 
for the outpatient clinic, age, and number of 
previous pregnancies, endometrial evaluation 
findings by transvaginal and / or abdominal 
ultrasonography, having periods or being at 
menopause status, results of endometrial D&C 
pathology before hysterectomy, hysterectomy 
indications, hysterectomy methods, and 
pathology results of hysterectomy 
materials were studied. 
The group with 162 patients who were 
undergone a D&C before the hysterectomy 
was named as the “biopsy group” and the 
group with 145 patients who were made the 
hysterectomy without a D&C was assigned as 
the “control group”. The groups were 
collectively compared in terms of demographic 
aspects with their clinical and pathological 
findings between and within themselves. 
The interpretation of endometrial evaluation 
by ultrasonography was made by measuring 
the endometrial double wall thickness by 
ultrasonographic endovaginal probe of 
Voluson Pro (General Electric, USA) and 
recorded in millimeters (mm). In the 
postmenopausal patients, if the endometrium 
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was thicker than 4 mm, in existence of 
irregularity, identified lesion or fluid in the 
cavity, endometrial sampling was performed. 
For the premenopausal patients, if   
endometrial thickness was >12 mm, lesion or 
irregularity in the cavity were detected, and 
abnormal uterine bleeding history was 
determined, endometrial biopsy was applied.  
The procedure of endometrial sampling was 
performed by D&C method under sedo-
analgesia in all cases. The histological 
reporting of the benign endometrial biopsies 
were classified as proliferative endometrium, 
secretory endometrium, simple endometrial 
hyperplasia without atypia, endometrial polyp, 
chronic endometritis, atrophic endometrium, 
irregular proliferative endometrium, and 
inadequate material. 
The term of indication of hysterectomy for a 
benign condition was assorted with diagnoses 
of    leiomyoma uteri, abnormal uterine 
bleeding (AUB), simple endometrial 
hyperplasia without atypia, adenomyosis, 
pelvic inflammatory disease (PID), chronic 
pelvic pain (CPP), endometrial polyp (EP) and 
uterovaginal prolapse (UVP). Patients with 
endometrial hyperplasia with atypia and 
complex endometrial hyperplasia, endometrial 
intraepithelial neoplasia, cervical 
intraepithelial neoplasia (CIN) 2-3, ovarian 
tumors and pre-existing gynecological cancer, 
family history of gynecological malignancies, 
high blood levels of CA 125 and CA19-9 were 
not included in the study. 
Types of hysterectomy in the study were 
recorded as laparoscopic hysterectomy, 
vaginal hysterectomy, and abdominal 
hysterectomy. 
 
Statistical analysis 
The analysis of the data was interpreted with 
the SPSS 23.00 program. Skewness-Kurtosis 
values were examined in the analysis for the 
normality test. The normality test of the scale 
was done to determine the test techniques to be 
used in the analysis and whether the 
distribution is normal. Since these values were 
between ± 2, it was accepted that normality for 
the values. Independent Samples t-test for 
comparison between 2 groups within the 
normal distribution of data, for 
the comparison of data that not distributed 
as normally, Mann-Whitney U test for 2 
groups and Kruskal-Wallis ANOVA test were 
used if there were over two groups. To analyze 
categorical variables, cross-tables were used 
and   p<0.05 value was regarded as significant 
for all analyses. Endometrial biopsy and 
pathology results were calculated as the 
number of patients and percentage.  
 
Results 
The biopsy group consisted of 162 patients and 
the control group consisted of 145 patients. 
Table 1 shows a comparison of demographic 
and clinical findings between the biopsy group 
and the control group. Mean Age, number of 
previous pregnancies (gravida), number of 
patients under the age of 40 and 
postmenopausal status did not differ 
significantly between the two groups 
(respectively; p= 0.916, p= 0.395, p= 0.125, 
p=0.125). 40.7% of the patients in the biopsy 
group has symptoms of postmenopausal 
bleeding, and they were significantly higher 
than the control group (p<0.001). 51.2% of 
patients in the biopsy group had symptoms of 
abnormal uterine bleeding in the 
premenopausal period and 52.5% of them were 
significantly higher than the control group 
(p<0.001, p<0.001). 
Table 2 shows the indications of hysterectomy 
of biopsy and control groups. Within the 
hysterectomy indications in the control group, 
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leiomyoma uteri (37.9%) was the most 
common in the control group, abnormal uterine 
bleeding was the second (22.8%) and 
uterovaginal prolapse was the third (16.6%). 
Within the hysterectomy indications in 
the biopsy group: abnormal uterine bleeding 
(52.5%) was the most common in 
the biopsy group, leiomyoma uteri was the 
second (28.4%), and endometrial 
polyp (5.6%) and uterovaginal prolapse 
(5.6%) were the third. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 shows the pathology results of the 
biopsy group before the hysterectomy. While 
the endometrial polyp was found to be the most 
common with 42.6%, it was determined 
secretory endometrium as 11.1%, irregular 
proliferative endometrium as 9.3%, atrophic 
endometrium as 8.6%, proliferative 
endometrium as 8%, endometrial hyperplasia 
as 6.8%, and chronic endometritis as 1.2% and 
insufficient material as 12.3%. 
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152 (49.5%) patients had abdominal, 128 
(41.7%) patients had total laparoscopic 
procedures and 27 patients (8.8%) had vaginal 
hysterectomy. 
Table 4 shows the distribution results of 
hysterectomy material pathology in two 
groups. One patient (0.7%) had 
leiomyosarcoma in the control group and one 
patient (0.7%) had endometrial endometrioid 
type of adenocarcinoma (e.e.adenoca). Five 
patients (3.1%) had endometrium 
endometrioid type adeno carcinoma in the 
biopsy group and significantly higher than the 
control group (p<0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The comparison of the results of endometrial 
biopsy pathology with results of hysterectomy 
material pathology is shown in Table 5. Two 
of the endometrial cancers were detected in 
patients with the endometrial polyp (40%) 
preoperative biopsy, 1 (20%) secretory 
endometrium, 1 (20%) simple endometrial 
hyperplasia, and 1 (20%) in those with 
insufficient material.  
Endometrial cancer has mostly been reported 
in patients with the postmenopausal bleeding 
symptom (80%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Distribution of hysterectomy pathology results between groups. 
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Discussion 
In our study, the incidence of unpredictable 
endometrial cancer was 0.7% in the control 
group, 3.1% in the biopsy group and 2% 
totally. The incidence of unpredictable 
leiomyosarcoma was 0.7% in the control group 
and 0.3% in the total. The incidence of 
unpredictable gynecological cancer was higher 
in studies with larger populations [6,7,14]. 
Ramm et al. (n = 708) detected cancer in five 
patients who were hysterectomized due to 
pelvic floor dysfunction. Among these five 
patients, two of them had an endometrial 
sampling, two had both endometrial sampling  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and ultrasonographic examination and one had 
only ultrasonographic examination for 
determining the underlying malignancy. In this 
study, they concluded that endometrial biopsy 
and ultrasonography should be performed 
before the surgery due to pelvic floor 
dysfunction [15]. In our study, patients who 
were detected a malignancy in the 
hysterectomy specimen were more common in 
the endometrial biopsy group and none were 
seen in those with pelvic floor dysfunction. 
Çelik et al. [3] (n = 200) found endometrial 
carcinoma after hysterectomy in one patient 
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who was hysterectomized with the diagnosis of 
leiomyoma. They reported that endometrial 
sampling was necessary for patients with 
postmenopausal leiomyoma and that in 
patients with premenopausal should be 
decided according to the endometrial 
thickness. Kucur et al. [16] (n = 744) reported 
the greatest risk for endometrial carcinoma in 
patients with postmenopausal bleeding (5.6%) 
and carried out that serious endometrial 
assessment and sampling should be performed 
in patients with postmenopausal bleeding. van 
Hanegem et al. [5] examined results 
of endometrial sampling of 12 studies 
involving 1029 women with postmenopausal 
bleeding, and it was found inadequate 
material in 11% of them and in 7% of them 
endometrial carcinoma was detected in their 
meta-analysis. It is more pointed out that the 
diagnosis study in women with 
postmenopausal bleeding should be done 
before hysterectomy. In our research, most of 
the patients with endometrial carcinoma were 
those with postmenopausal bleeding. In our 
study, 12.3% inadequate endometrial sampling 
was detected and one case with endometrial 
cancer was found among them. Yumuşak et al. 
[17] (n = 198) reported that preoperative 
endometrial sampling had a low potential in 
patients with hysterectomy with benign 
preliminary diagnoses. Ercan et al. [18] (n = 
332) reported that two patients presented with 
postoperative endometrial carcinoma in the 
presence of endometrial complex hyperplasia 
with atypia in the preoperative biopsy and that 
these patients had abnormal uterine bleeding 
and they concluded that routine endometrial 
sampling were unnecessary in patients with 
benign hysterectomy. Similarly, in our study, 
endometrial carcinoma has not been observed 
in patients without abnormal uterine bleeding. 
Hinchcliff et al. [19] (n = 329) reported that 
endometrial biopsy was inadequate in the 
diagnosis of uterine sarcoma. In our study, no 
sarcomas were found in the biopsy group. Only 
one case with leiomyosarcoma was seen in the 
control group.  
The relatively low numbers of patients and the 
fact that the cases with abnormal uterine 
bleeding and postmenopausal bleeding cannot 
constitute a homogenous distribution among 
the groups may be mentioned as limitations of 
our study. An attentive endometrial 
examination for the patients who will have 
hysterectomy is already crucial but frankly, not 
all the patients need to have an endometrial 
sampling prior to surgery. Additionally, it must 
be kept in mind that, endometrial sampling 
may also skip a portion of endometrial 
malignancies as found in our biopsy group 
patients.  
 
Conclusion 
In patients who will scheduled for a 
hysterectomy secondary to benign 
gynecological disorders and conditions, there 
is no need for performing of routine a 
endometrial biopsy in absence of symptoms 
such as clinical, and radiological findings 
suggesting an endometrial malignancy. In 
patients with postmenopausal bleeding, 
although the result of preoperative endometrial 
sampling pathological examination is benign, 
it is useful that performing frozen section 
pathological examination of hysterectomy 
material during operation for a detailed and 
better attitude to exclude a potentially 
coexisting endometrial carcinoma. 
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